Standout Papers

EFNS guidelines on the Clinical Management of Amyotrophic Lateral Scler... 2006 2026 2012 2019 762
  1. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force (2011)
    Peter M. Andersen, Sharon Abrahams et al. European Journal of Neurology
  2. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis (2006)
    Matthew Greenway, Peter M. Andersen et al. Nature Genetics
  3. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? (2011)
    Peter M. Andersen, Ammar Al‐Chalabi Nature Reviews Neurology
  4. European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD) (2024)
    Philip Van Damme, Ammar Al‐Chalabi et al. European Journal of Neurology

Immediate Impact

8 by Nobel laureates 19 from Science/Nature 98 standout
Sub-graph 1 of 14

Citing Papers

A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
2024 Standout
Amyotrophic lateral sclerosis
2022 Standout
60 intermediate papers

Works of Peter M. Andersen being referenced

Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion
2018
EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force
2011 Standout
and 54 more

Author Peers

Author Last Decade Papers Cites
Peter M. Andersen 9527 5295 3589 222 12.6k
Vincent Meininger 10063 5660 3678 211 13.8k
P. Nigel Leigh 9478 4311 3104 164 12.6k
Martin R. Turner 10427 4830 3003 253 13.7k
Lucette Lacomblez 6920 3514 2328 152 10.1k
Adriano Chiò 16057 9337 4720 369 20.0k
Ammar Al‐Chalabi 14418 8052 5416 266 17.7k
Steve Vucic 9541 4488 2328 304 12.8k
Leonard H. van den Berg 8642 4201 3245 258 12.6k
Michael J. Strong 7166 3547 3107 212 10.4k
Jan H. Veldink 7059 3750 2767 200 9.6k

All Works

Loading papers...

Rankless by CCL
2026